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Available online xxxThe Covid-19 pandemic has highlighted the longstanding under
representation of ethnic minorities in clinical research  including
migrant populations [1]. Ethnic minorities in the UK are at signifi-
cantly greater risk of severe disease and death from Covid-19 than
their White counterparts [2]. Similarly, migrants in high-income
countries with Covid-19 have been identified as being at potentially
greater risk of hospitalisation and death than non-migrants [3].
Despite this, a recent National Institute for Health Research (NIHR)
report found ethnic minorities constitute only 9¢26% of participants
in UK Covid-19 studies, below their representation in the general
population (13¢80%) [4].
The NIHR has stated that Covid-19 research needs more ethnic
minority participants to ensure the research is representative of the
UK population. The inclusion of these groups in Covid-19 vaccine tri-
als is particularly pertinent, with vaccine uptake being lower among
ethnic minority groups than White people in the UK despite their
increased risk [5]. Some migrant group’s concerns around the vaccine
are due to their lack of inclusion in the clinical trials, highlighting an
urgent need to understand and address the reasons underlying these
disparities in Covid-19 research participation [6].
Reasons for the underrepresentation of ethnic minority groups in
Covid-19 research are poorly elucidated but are likely due to a combi-
nation of personal and structural factors. Socio-political factors may
include social deprivation limiting access to health services, and sub-
sequently, participation in  and awareness of  health research.
Participant-related factors may include language and cultural bar-
riers, and mistrust towards researchers and research institutions.
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ethnic exclusion. Previous studies have noted that a good researcher-
participant relationship is a key facilitator of their participation [7].
Lack of ethnic minority participation has also been linked to racial
discrimination and previous negative healthcare experiences [5]. A
qualitative study in the UK seeking the views of ethnic minorities
towards participation in Covid-19 vaccine trials identified a range of
barriers including concerns around attending hospitals, lack of sup-
port if problems arose and language barriers between themselves
and research staff, despite agreement that this research was neces-
sary [8].
Factors relating to research design and approach taken by
researchers, including the omission of ethnicity from covariate data
and non-inclusive recruitment strategies, are also likely to impact
negatively on recruitment from these communities. As of 27th March
2021, only 1¢43% of US-based studies investigating Covid-19 regis-
tered on Clinicaltrials.gov were collecting data about ethnicity,
highlighting how this problem continues to go overlooked. Another
review examining ethnic minority research participation found that
the number of individuals from minority groups actually invited by
researchers to participate in research was disproportionately small
compared to their representation in the wider population [9]. Strate-
gies to increase ethnic minority representation in medical research
must seek to tackle the root causes of underrepresentation including
systemic racism, racial discrimination and access barriers.
In-depth cross-sectoral qualitative research is urgently needed to
better understand the barriers hindering the involvement of people
from ethnic minority communities in clinical research and develop
robust solutions. Initiatives such as the INCLUDE project, which aims
to promote the inclusion of underserved communities in clinical tri-
als, are forming the basis for this much needed work and may provide
fresh insight and useful action points [10]. Researchers and policy
makers should be educated and supported to prioritise equitable
access to research participation for ethnic minorities and migrants,
particularly for conditions that disproportionately affect them. Strat-
egies for overcoming participation disparities should not be ad hoc,
but rather, part of a policy framework underpinned by Principle 13 of
the Declaration of Helsinki. Practical solutions for increasinger the CC BY license (http://creativecommons.org/licenses/by/4.0/)
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guages other than English, using diverse recruitment strategies to ensure
study information and invitations reach potential participants among
ethnic minority and migrant communities, and developing community
engagement programmes to dispel rumours and misinformation which
may erode trust in these studies [8]. Addressing factors connected to eco-
nomic disadvantage (which may disproportionately affect certain ethnic
minority groups) will also be needed, including reimbursement for child-
care costs and travel expenses [9]. Being clear about the potential bene-
fits of participation will be important, alongside consideration of cultural
and religious schedules [8].
The NHS Race & Health Observatory, which has responded to the
specific health and wellbeing of ethnic groups in the UK, should now
also focus on the equitable inclusion of these groups in Covid-19 clin-
ical research and trials. Ultimately, we should ensure meaningful par-
ticipation is placed at the heart of public health interventions
research, with beneficiaries of the research included in every stage of
the research pathway [6].Declaration of Competing Interest
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